Literature DB >> 22245804

Multiple myeloma.

Antonio Palumbo.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22245804     DOI： 10.1097/01.cco.0000410242.38332.78

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN： 1040-8746            Impact factor:   3.645


× No keyword cloud information.
  4 in total

Review 1.  MicroRNA theragnostics for the clinical management of multiple myeloma.

Authors:  N Ahmad; S Haider; S Jagannathan; E Anaissie; J J Driscoll
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

2.  Mechanism of exosomal miR-155 derived from bone marrow mesenchymal stem cells on stemness maintenance and drug resistance in myeloma cells.

Authors:  Xinyu Gao; Jin Zhou; Jinghua Wang; Xiushuai Dong; Yuying Chang; Yinglan Jin
Journal:  J Orthop Surg Res       Date:  2021-10-24       Impact factor: 2.359

3.  The short-term effect of histone deacetylase inhibitors, chidamide and valproic acid, on the NF‑κB pathway in multiple myeloma cells.

Authors:  Zhaoyun Liu; Qian Jing; Yangyang Wang; Yanqi Li; Fu Mi; Chenhuan Xiang; Rong Fu
Journal:  Int J Mol Med       Date:  2018-10-29       Impact factor: 4.101

4.  Higher single dose of bortezomib plus thalidomide and dexamethasone is a promising therapy for newly diagnosed multiple myeloma.

Authors:  Peipei Xu; Rongfu Zhou; Jingyan Xu; Jian Ouyang; Xiaoyan Shao; Bing Chen
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.